KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non-cash Items: 2014-2020

Historic Non-cash Items for Aurinia Pharmaceuticals (AUPH) over the last 4 years, with Sep 2020 value amounting to $79.9 million.

  • Aurinia Pharmaceuticals' Non-cash Items rose 68.93% to $79.9 million in Q3 2020 from the same period last year, while for Sep 2020 it was $79.9 million, marking a year-over-year increase of 68.93%. This contributed to the annual value of -$65.5 million for FY2019, which is 43.58% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Non-cash Items stood at $79.9 million for Q3 2020, which was up 84.95% from $43.2 million recorded in Q2 2020.
  • In the past 5 years, Aurinia Pharmaceuticals' Non-cash Items ranged from a high of $79.9 million in Q3 2020 and a low of -$21.3 million during Q1 2020.
  • For the 3-year period, Aurinia Pharmaceuticals' Non-cash Items averaged around $28.1 million, with its median value being $26.3 million (2019).
  • Data for Aurinia Pharmaceuticals' Non-cash Items shows a peak YoY increase of 68.93% (in 2020) and a maximum YoY decrease of 274.79% (in 2020) over the last 5 years.
  • Aurinia Pharmaceuticals' Non-cash Items (Quarterly) stood at $33.1 million in 2018, then spiked by 42.76% to $47.3 million in 2019, then skyrocketed by 68.93% to $79.9 million in 2020.
  • Its Non-cash Items was $79.9 million in Q3 2020, compared to $43.2 million in Q2 2020 and -$21.3 million in Q1 2020.